已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Abstract 3663: A gene signature for predicting outcome in patients with basal-like breast cancer

作者
Robin M. Hallett,Anna Dvorkin‐Gheva,Anita L. Bane,John A. Hassell
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:72 (8_Supplement): 3663-3663
标识
DOI:10.1158/1538-7445.am2012-3663
摘要

Abstract Basal-like breast cancer is a molecular subtype of breast cancer generally thought to have a universally poor prognosis. Subsequent studies examining the long-term outcome in thousands of patients with basal-like breast cancer have shown that these patients can be separated into two clinically distinct groups: those likely to experience a systemic recurrence and succumb to their disease within the first 5 years and those expected to show excellent long term survival. The ability to distinguish between these two sub-groups (good and poor prognosis) of basal-like breast cancer patients at the time of initial diagnosis would permit tailoring more aggressive therapeutic regimens to those patients with an inherently poorer prognosis and conversely to avoid such therapy in patients with a more indolent course. We aimed to identify a gene signature that could predict the clinical outcome of basal-like breast cancer patients. To this end we mined publicly available human breast tumor gene expression profiling data and identified patients with basal-like breast cancer. We divided these patients into training and validation sets to identify and confirm the accuracy of a prognostic signature. We identified 137 basal-like breast tumors among 995 breast tumor gene expression profiles. We used 85 of these samples as a training group and identified an optimal 14-gene signature, which accurately identified patients that experienced poor and good long-term survival. We confirmed the accuracy of our gene signature on a 49 patient independent validation set. Importantly, we also confirmed the capacity of our signature to predict outcome in a chemotherapy naïve 27 patient sub-set of the 49 patients validation set. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3663. doi:1538-7445.AM2012-3663

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
司徒宝完成签到,获得积分10
刚刚
豆豆哥完成签到 ,获得积分10
2秒前
5秒前
qiu发布了新的文献求助10
10秒前
无花果的应助被仄言采纳,获得10
12秒前
开放诗完成签到 ,获得积分10
12秒前
Cassie完成签到,获得积分0
16秒前
无心的乾发布了新的文献求助10
18秒前
欣欣完成签到,获得积分10
18秒前
Owen的应助被黑默丁格采纳,获得10
20秒前
21秒前
意义完成签到,获得积分10
21秒前
23秒前
23秒前
24秒前
朱广能发布了新的文献求助30
26秒前
willlee发布了新的文献求助10
28秒前
甜橙发布了新的文献求助10
28秒前
hhhx11112222发布了新的文献求助50
29秒前
30秒前
30秒前
30秒前
30秒前
FashionBoy的应助被武陵济世采纳,获得10
31秒前
达之强发布了新的文献求助10
34秒前
斯文败类的应助被南山采纳,获得10
35秒前
zhuzuokun完成签到 ,获得积分10
35秒前
土豆子汁发布了新的文献求助20
35秒前
鱼子完成签到,获得积分10
36秒前
xmm完成签到 ,获得积分10
38秒前
华仔的应助被无心的乾采纳,获得10
38秒前
38秒前
40秒前
爱学习的考拉完成签到 ,获得积分10
42秒前
小马甲的应助被橙啊程采纳,获得10
44秒前
惠惠子发布了新的文献求助10
44秒前
欢喜初雪发布了新的文献求助10
44秒前
Ammr发布了新的文献求助10
45秒前
45秒前
神明发布了新的文献求助10
45秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Composite Materials Handbook Volume 1 - Revision H 1000
Composite Materials Handbook Volume 3 - Revision H 1000
Rosenblum, Global Change Biology 800
Computational Chemical Reaction Engineering: Modeling, Simulation, and Design with MATLAB 600
Organizational Behavior 510
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7806236
求助须知:如何正确求助?哪些是违规求助? 9339377
关于积分的说明 20496667
捐赠科研通 7398248
什么是DOI,文献DOI怎么找? 3328021
关于科研通互助平台的介绍 2474759
邀请新用户注册赠送积分活动 2346147